A Registry of Peripartum Cardiomyopathy in Turkey

Clinical A Nation-wide Registry of Peripartum Cardiomyopathy: Clinical Status in Turkey

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

Peripartum cardiomyopathy (PPCM) is a global disease with significant morbidity and mortality of young women. Its' etiology, epidemiology and treatment is not yet well described. This will be a retrospective, national, multicenter observational study, conducted in centres in Turkey. It is expected that approximately 50 women with PPCM will be recorded.

The objectives of the study are:

To define the clinical status and clinical characteristics of PPCM in Turkey

To define the outcome of PPCM (short and long term)

To define the demographical and possible etiological factors

To define prognostic factors

Inclusion Criteria:

• Patient above 18 years of age
• Unexplained Heart Failure symptoms developed towards the end of pregnancy or in the first 6 months of postpartum period
• Ejection fraction less than 45% documented with echocardiography

Exclusion Criteria:

• Patients with any other known cardiac pathology